Stock Price

Azitra will present its novel AI-driven skin therapies for rare diseases at Biotech Showcase, seeking crucial funding and partnerships to advance its pipeline.

Amid rising geopolitical risks, Taiwan's J-Star is exiting China to build an automated factory in the US, a bold move for the micro-cap company.

CleanSpark boosts Bitcoin output by over 10% and pivots to AI data centers, all while helping stabilize the power grid in times of extreme demand.

With its massive data library and AI platforms, Tempus AI prepares for a pivotal presentation. What will CEO Eric Lefkofsky reveal to investors?

Processa Pharmaceuticals completes enrollment for a pivotal analysis of its NGC-Cap therapy, offering new hope for a safer, more effective cancer treatment.

Solmate Infrastructure appoints financial heavyweight Erez Simha to its board, bolstering its ambitious plan to build a Solana hub in Abu Dhabi.

Occidental nets $9.7B from its OxyChem sale to Berkshire Hathaway, pivoting to oil and carbon capture while retaining significant environmental liabilities.

Intelligent Bio Solutions raised crucial capital for its fingerprint drug test, but the deal's structure sent shares tumbling amid shareholder dilution fears.

Just months after its IPO, Kandal M Venture is fighting to stay on Nasdaq. We explore the financial woes behind the stock's dramatic fall.

As Northern Trust prepares its Q4 2025 earnings call, investors seek clues on its resilience amid shifting economic tides and strategic digital pivots.

Mixed Martial Arts Group lands $3 million in funding, with Donald Trump Jr. investing, to fuel its ambitious blockchain-based fan engagement platform.

Eightco Holdings bets big on its own stock with a $125M buyback, banking on its Worldcoin treasury and a vision for AI-proof digital identity.

Chegg repurchases convertible notes at a discount, a calculated move to strengthen its finances as it pivots to the competitive skilling market.

Setrusumab, a promising drug for Osteogenesis Imperfecta, failed to reduce fractures in key trials, triggering a market collapse and strategic overhaul.

As 374Water pushes its waste-destroying tech to market, a new board member with deep financial expertise and a history as a long-term investor joins.

iQSTEL caps a transformational year with a NASDAQ uplist, record revenue, and a strategic pivot to Fintech and Cybersecurity, eyeing a $1B future.

Gogo has launched its anticipated 5G network for business jets, promising a new era of speed. But can its regional advantage hold against global satellite rivals?

EUDA Health's new Helixé 2.0 supplement boasts enhanced potency, nano-delivery tech, and Halal certification to capture the booming global wellness market.

Tevogen's Dr. Ryan Saadi donates over $88,000 in company stock to a UN-recognized charity, bolstering educational programs for underserved children.

Mirum raises over a quarter-billion dollars to acquire Bluejay Therapeutics, targeting a high-potential liver disease drug and signaling major growth.